Compare INBX & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INBX | SCL |
|---|---|---|
| Founded | 2010 | 1932 |
| Country | United States | United States |
| Employees | 161 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | N/A |
| Metric | INBX | SCL |
|---|---|---|
| Price | $72.00 | $51.67 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 218.5K | 180.6K |
| Earning Date | 11-14-2025 | 02-18-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.98 |
| Revenue | $1,400,000.00 | ★ $2,303,837,000.00 |
| Revenue This Year | $563.00 | $8.79 |
| Revenue Next Year | N/A | $8.14 |
| P/E Ratio | ★ N/A | $26.07 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | $10.81 | $41.82 |
| 52 Week High | $94.57 | $65.89 |
| Indicator | INBX | SCL |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 70.99 |
| Support Level | $69.47 | $46.70 |
| Resistance Level | $76.47 | $52.61 |
| Average True Range (ATR) | 4.77 | 1.27 |
| MACD | -0.76 | 0.26 |
| Stochastic Oscillator | 20.55 | 81.22 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.